您的位置: 首页 > 农业专利 > 详情页

Naltrexone Long Acting Formulations and Methods of Use
专利权人:
Alkermes Pharma Ireland Limited
发明人:
Elliot Ehrich
申请号:
US15486869
公开号:
US20180064814A1
申请日:
2017.04.13
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The inventions described herein arose from unexpected discoveries made during clinical trials with a long acting formulation of naltrexone. As such, the invention includes a method for treating an individual in need of naltrexone comprising the step of parenterally administering a long acting formulation comprising naltrexone and to the use of naltrexone in the manufacture of medicaments for use in such methods.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充